This webinar is about genetic testing to guide cannabis therapy, emphasizing the importance of personalized medicine.
The session is introduced by Dr. Adam Abodeely, a colorectal surgeon and cannabis physician, who highlights the growing demand and potential of medical cannabis.
Dr. Rye Wagner from Greenway DNA details the company's approach to genetic testing, explaining how it can aid in determining the optimal dosage of CBD and THC for conditions like anxiety, pain, and insomnia. He discusses the endocannabinoid system, the medical cannabis consumer dilemma, and the complexity of genetic variations.
The session also features Len May from Endocanna Health, who shares his personal journey and the technology behind their DNA test.
Both speakers stress the importance of accurate dosing and potential drug interactions. They advocate for the collaboration between genetic testing and healthcare providers to ensure safe and effective cannabis therapy.
The Q&A session addresses concerns about the influence of cannabis naivety versus chronic use, the integration of genetic information with clinical histories, and the cost and insurance coverage of these tests. Both experts agree that genetic testing should be embraced broadly as a tool to enhance personalized care and avoid adverse events.